News
6d
MedPage Today on MSNTolebrutinib Benefits Non-Relapsing Secondary Progressive Multiple SclerosisSAN DIEGO -- Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive ...
A novel AI tool called MindGlide extracts key biomarkers from MRI scans to help interpret and assess treatment efficacy in ...
The following is a summary of “Limited added value of systematic spinal cord MRI vs brain MRI alone to classify patients with ...
Can your brain start consuming itself during a marathon? New research says yes- but don’t panic, your brain bounces back in ...
Rituximab, a lower-cost treatment, may be as effective at managing RRMS as the approved therapy Ocrevus, a new study from ...
HIGHER lesion burden in the uncinate fasciculus (UF), a key brain pathway linking emotional regulation regions, is associated with increased anxiety severity in multiple sclerosis (MS) patients, ...
Tolebrutinib, a brain-penetrant BTK inhibitor, may fill a significant unmet need by delaying disability progression in patients with non-relapsing secondary progressive multiple sclerosis.
Data from an open-label extension of VISIONARY-MS support an association between gold nanocrystals and neuronal repair and remyelination in patients with stable multiple sclerosis and visual deficits, ...
5d
MedPage Today on MSNCase Study: Why Is a Teen Having All These Bizarre Symptoms?As they described in Radiology Case Reports, the patient noted that she had been having increasing weakness in her left arm ...
What begins as ringing in the ears, dizziness or ear pain might seem like a routine infection, but for some individuals, ...
In people with schizophrenia, NfL levels appeared to increase more quickly with age, compared with the rate of increase in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results